Literature DB >> 18337816

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.

Hye-Jung Han1, Jose Russo, Yoshinori Kohwi, Terumi Kohwi-Shigematsu.   

Abstract

Mechanisms underlying global changes in gene expression during tumour progression are poorly understood. SATB1 is a genome organizer that tethers multiple genomic loci and recruits chromatin-remodelling enzymes to regulate chromatin structure and gene expression. Here we show that SATB1 is expressed by aggressive breast cancer cells and its expression level has high prognostic significance (P < 0.0001), independent of lymph-node status. RNA-interference-mediated knockdown of SATB1 in highly aggressive (MDA-MB-231) cancer cells altered the expression of >1,000 genes, reversing tumorigenesis by restoring breast-like acinar polarity and inhibiting tumour growth and metastasis in vivo. Conversely, ectopic SATB1 expression in non-aggressive (SKBR3) cells led to gene expression patterns consistent with aggressive-tumour phenotypes, acquiring metastatic activity in vivo. SATB1 delineates specific epigenetic modifications at target gene loci, directly upregulating metastasis-associated genes while downregulating tumour-suppressor genes. SATB1 reprogrammes chromatin organization and the transcription profiles of breast tumours to promote growth and metastasis; this is a new mechanism of tumour progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337816     DOI: 10.1038/nature06781

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  251 in total

1.  Cross-analysis of gene and miRNA genome-wide expression profiles in human fibroblasts at different stages of transformation.

Authors:  Paola Ostano; Silvia Bione; Cristina Belgiovine; Ilaria Chiodi; Chiara Ghimenti; A Ivana Scovassi; Giovanna Chiorino; Chiara Mondello
Journal:  OMICS       Date:  2012 Jan-Feb

2.  Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.

Authors:  Arvydas Laurinavicius; Aida Laurinaviciene; Valerijus Ostapenko; Darius Dasevicius; Sonata Jarmalaite; Juozas Lazutka
Journal:  Diagn Pathol       Date:  2012-03-16       Impact factor: 2.644

3.  Satb1 ablation alters temporal expression of immediate early genes and reduces dendritic spine density during postnatal brain development.

Authors:  Michael A Balamotis; Nele Tamberg; Young Jae Woo; Jingchuan Li; Brian Davy; Terumi Kohwi-Shigematsu; Yoshinori Kohwi
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 4.  The nucleoskeleton as a genome-associated dynamic 'network of networks'.

Authors:  Dan N Simon; Katherine L Wilson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-10-05       Impact factor: 94.444

Review 5.  Higher-order genome organization in human disease.

Authors:  Tom Misteli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-30       Impact factor: 10.005

6.  Re: The role of SATB1 in breast cancer pathogenesis.

Authors:  Terumi Kohwi-Shigematsu; Hye-Jung Han; Jose Russo; Yoshinori Kohwi
Journal:  J Natl Cancer Inst       Date:  2010-11-12       Impact factor: 13.506

Review 7.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.

Authors:  Dawn M Carone; Jeanne B Lawrence
Journal:  Semin Cancer Biol       Date:  2012-06-18       Impact factor: 15.707

Review 8.  Genome organizing function of SATB1 in tumor progression.

Authors:  Terumi Kohwi-Shigematsu; Krzysztof Poterlowicz; Ellen Ordinario; Hye-Jung Han; Vladimir A Botchkarev; Yoshinori Kohwi
Journal:  Semin Cancer Biol       Date:  2012-07-04       Impact factor: 15.707

9.  New advances in breast cancer metastasis.

Authors:  Jose Russo; Hye-Jung Han; Yoshinori Kohwi; Terumi Kohwi-Shigematsu
Journal:  Womens Health (Lond)       Date:  2008-11

Review 10.  Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma.

Authors:  Chuck C K Chao
Journal:  World J Hepatol       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.